| Name | 3-(2-piperidin-1-ylethyl)-1H-benzimidazol-2-one |
|---|---|
| Synonyms |
1-[2-(1-piperidinyl)ethyl)-1,3-dihydro-2H-benzimidazol-2-one
2H-Benzimidazol-2-one,1,3-dihydro-1-[2-(1-piperidinyl)ethyl] 1-(2-piperidin-1-ylethyl)-1,3-dihydro-2H-benzimidazol-2-one 1-(2-piperidin-1-yl-ethyl)-1,3-dihydro-benzoimidazol-2-one |
| Molecular Formula | C14H19N3O |
|---|---|
| Molecular Weight | 245.32000 |
| Exact Mass | 245.15300 |
| PSA | 41.29000 |
| LogP | 2.16570 |
|
~%
101116-44-3 |
| Literature: Cereda, Enzo; Maiocchi, Luciano; Brambilla, Alessandro; Giraldo, Ettore; Monferini, Eugenia; Schiavi, Giovanni Battista Patent: US2003/27823 A1, 2003 ; |
|
~%
101116-44-3 |
| Literature: NOGRA PHARMA LIMITED; HOMMES, Daan; VERHAAR, Auke; VAN DEN BRINK, Gijs; VITI, Francesca Patent: WO2013/178815 A1, 2013 ; |
|
~%
101116-44-3 |
| Literature: NOGRA PHARMA LIMITED; HOMMES, Daan; VERHAAR, Auke; VAN DEN BRINK, Gijs; VITI, Francesca Patent: WO2013/178815 A1, 2013 ; Location in patent: Paragraph 00116; 00117 ; |
| Precursor 4 | |
|---|---|
| DownStream 0 | |